沈意翔, 徐超斗, 高秀华, 林德昌, 刘皋林. 盐酸苯丙醇胺控释混悬剂和普通片在健康志愿者多剂量生物利用度比较J. 药学学报, 1995, 30(2): 157-160.
引用本文: 沈意翔, 徐超斗, 高秀华, 林德昌, 刘皋林. 盐酸苯丙醇胺控释混悬剂和普通片在健康志愿者多剂量生物利用度比较J. 药学学报, 1995, 30(2): 157-160.
YXshen, CDXu, XHGao, DC Lin,GLLiu, . COMPARIS0N 0F MULTIPLE DOSAGE BI0AVAILABILITY BETWEEN PHENYLPROPANOLAMINE CONTROLLED RELEASE SUSPENSI0N AND CONVENTI0NAL TABLET IN HEALTHY VOLUNTEERSJ. Acta Pharmaceutica Sinica, 1995, 30(2): 157-160.
Citation: YXshen, CDXu, XHGao, DC Lin,GLLiu, . COMPARIS0N 0F MULTIPLE DOSAGE BI0AVAILABILITY BETWEEN PHENYLPROPANOLAMINE CONTROLLED RELEASE SUSPENSI0N AND CONVENTI0NAL TABLET IN HEALTHY VOLUNTEERSJ. Acta Pharmaceutica Sinica, 1995, 30(2): 157-160.

盐酸苯丙醇胺控释混悬剂和普通片在健康志愿者多剂量生物利用度比较

COMPARIS0N 0F MULTIPLE DOSAGE BI0AVAILABILITY BETWEEN PHENYLPROPANOLAMINE CONTROLLED RELEASE SUSPENSI0N AND CONVENTI0NAL TABLET IN HEALTHY VOLUNTEERS

  • Abstract: Compared studies between the pharmacokinetics of phenylpropanolamine(PPA)controlled release suspension ( CRS ) and that of PPA conventional tablet in l0 healthy volunteers showed that the maximal plasma concentration(Cmax), the minimal plasma concentration(Cmin)and the fluctuation index (FI) values were 169. 06±7. 76 ng· ml-1, 82. 80±4; 29 ng· ml-1and 0. 20 ±0. 04 respectively for PPA CRS, 180. 05±8. 91 ng· ml-1, 76. 18±5. 97 ng·ml-1and 0.81±0.07 respectively for the conventional tablet. The Cnaxand FI of PPA CRS were significantly lower compared with those of the conventional tablet(P<0. 01 ) during steady state, The Cmin of PPA CRS was higher than that of the conventional tablet(P<0. 05)。

     

/

返回文章
返回